Daschle served almost two decades in the Senate and was majority leader from 2001 to 2003 while Democrats controlled the chamber.

He has also been called a "high-profile pick" for the department of constitution and human services. The mechanism he will lead oversees programs such as Medicare, the federal health cover plan for people throughout the age of 65, which is expected to see costs balloon as the U.S. population ages.

The be subject to is liable to to spearhead Obama’s charge to extend health-care coverage to 47 million uninsured Americans, a key promise of his presidential campaign.

UD plans to ask conducive to pre-candidate standing for its Rather high school from the Accreditation Council for Pharmacy Education (ACPE) and expects to enroll its first class in 2011, following fitting approvals from ACPE as well as other accreditation and regulatory bodies.

UD has named salubrity sciences administrator and educator Dr. George E. MacKinnon III founding dean and professor of the pharmacy school. He times held leadership roles in the establishment and accreditation of two additional schools of pharmacy in Chicago and Phoenix, as well as conducted feasibility studies for schools of pharmacy at other universities.

MacKinnon has also delivered more than 200 presentations, written more than 60 publications, and authored three book chapters in the pharmacy and the health sciences arenas. “MacKinnon brings to this important position decades of invaluable clinical, academic, and administrative experience in the strength sciences,” Dr. Francis M. Lazarus, president of the University of Dallas, said. “His leadership will prove instrumental in building the creed of pharmacy and at the end of the day positioning it as one of the most innovative schools of pharmacy in the country.” Before his appointment at UD, MacKinnon was the vice president of academic affairs at the American Association of Colleges of Pharmacy.

Over the past 18 years, MacKinnon held joint academic appointments in medicine and pharmacy at dissimilar schools, charming in clinical practice, research, teaching, and academic administration. He has also worked in the pharmaceutical industry as director of wide-ranging health economics and outcomes experimentation at Abbott Laboratories. A six-month feasibility mull over led by outside consultants helped to determine both the need for a college of pharmacy in the region and UD’s unique qualifications.

As both Texas and the United States are facing a critical shortage in the number of licensed pharmacists to distend existing positions, the university will stop provide the shortage. Texas currently ranks 42nd to of 50 states in meeting the demand for new pharmacists, yet is the second most populated state. There are 95,000 applicants for only 10,000 first-year enrollment spots at pharmacy schools. The Texas Workforce Commission estimates the state needs 855 new pharmacists annually, yet Texas’ six pharmacy schools combined alone assemble 650 graduates each year. Historically, Texas has had to attract pharmacists from other states to fill vacant apothecary positions.

"I look forward to addressing the missing piece of the robust healthcare infrastructure in North Texas, in partnership with regional healthcare practitioners, institutions, and communities, and creating a patient-centered curriculum for our students," MacKinnon said. "This is a tremendous opportunity to build on UD’s national prominence and reputation with respect to student-centered education and the advancement of snoopy, caring, and critical thinkers to each its graduates."

The growing demand due to the fact that licensed pharmacists has been driven by a number of factors, including the state’s rapidly aging residents, the increased role of pharmaceuticals as the leading course of medical intervention, and the expansion of pharmacy services in retail outlets and medical centre settings nationwide.

In addition, licensed pharmacists are increasingly taking positions in settings, such as long-term care facilities, hospice care, formula emoluments management companies, clinical research, pharmaceutical companies, policy and regulatory affairs, governmental agencies, and mail-order distribution companies.

About the AuthorAlaina Scott, Senior EditorAbout Alaina Scott, Senior Editor
See more articles by Alaina Scott, Senior EditorKeep Connected - Sign Up Now

Sign up now to earn weekly updates from Drug Topics.

The St. Louis-based firm said last week that in early October it received a letter that included the names, birth dates, Social Security numbers and, in some cases, prescription data of some customers. The authors also threatened to expose millions of consumer records if the company declined to pay up, Express Scripts said.

The company handles roughly 500 million prescriptions a year for the treatment of about 50 million Americans. Since the company has said it has no intention of paying the ransom, the attackers come up to be annoying new tactics. Express Scripts said the extortionists have began immediately contacting companies who use their services, by sending letters to the companies which include critical and medical information of their employees. Express Scripts spokesman Stephen Littlejohn said the company is still working with the FBI to track down the extortionists, but that there were no new leads to report. He said the new round of extortion demands targeted a "small number of clients and some members for the sake of each of those clients," but he declined to disclose how many. "We are cooperating fully with the FBI to assist them in their investigation and doing what we can to safeguard our members," said George Paz, CEO and Chairman of Express Scripts. "We hope that establishing a reward will stage a revive foster useful information. We will do what we can to assist arouse those responsible as quickly as possible."

In a separate notice, Express Scripts said it would put up for sale its members free identity restoration services if they become victims of identity embezzlement because of this incident. "Express Scripts recognizes that this location is relating to to our clients and members," Paz said. "We call for to assure them that they will have our constant affirm until their issues are resolved." Express Scripts is one of the largest apothecary benefit management firms.

While it doesn’t interact with consumers directly, the company’s pre-eminence is printed on formula cards of health care plans that use its services. The company has set up a Web site where consumers can go to learn more everywhere the incidents.

Meanwhile, Express Scripts said it has contracted with Kroll, a New York-based risk-consulting firm and global statistics security boss, to offer expert assistance to its members if they appropriate for victims of identity theft . The members will accept access to Kroll’s expert consultants and licensed investigators who will line with them to evaluate their cases and verify the appropriate course of combat.

Express Scripts said that it is not aware of any actual misuse of its members’ figures.

Anyone with information can call the FBI at 800-CALL-FBI.

Competition bulk retail outlets and healthcare facilities is fierce, and the on — salaries typically start around $120,000 — is high. To lure pharmacists, retailers are dangling incentives. For a while, solitary even explain recruits behind the wheel of a BMW, according to newspaper reports.

Behind the shortage is an aging population in need of skilled advice and an increasing demand championing pharmaceuticals that is solitary expected to accelerate in the years to come. Job growth - and competition - is also being driven by the expansion of retail giants such as Walgreens, Rite Aid, and CVS.

 Though some pharmacy schools aimed at churning out more highly-trained professionals have popped up across the country, demand still outstrips diplomas. In Kaiser Permanente’s Northern California region, 8 percent of its pharmacist jobs are unspoken for, Frank Hurtarte, the director of recruitment services for Kaiser facilities from the Bay Area to the foothills, said.

Kaiser has 154 pharmacies in the region and filled 24.6 million prescriptions last year, according to its Web site. Hurtarte said Kaiser Permanente advertises in journals, gives referral bonuses, and offers signing bonuses of as much as $20,000 While the struggling economy has caused drug sales to dip, experts sway the long-term demand for pharmacists will continue. New pharmacy schools have opened in response to the high demand in the field. The United States now has 106, according to the American Association of Colleges of Pharmacy. Just seven years ago, the U.S. apothecary graduates numbered 29 for every million people. Last year, the number rose to 33 graduates per million, according to Knapp and others.

Next elasticity, Touro is scheduled to grant degrees to 62 Rather students, its first class of graduates. In fact, enrollment at drugstore schools has risen for seven straight years. In fall 2007, 3,956 full-time students were enrolled nationwide - hardly adequate to fill the 3,904 jobs vacant in January 2007 at retail pharmacies, according to the National Association of Chain Drug Stores.

 To earn a doctor of apothecary lengths, students must undergo at least two years of undergraduate college surely incite followed by four impractical years of professional study, according to the American Association of Colleges of Pharmacy’s Web site.

"With a tremendous dearth of pharmacists, there are thousands of students distressing to get in," said David Hawkins, dean of California Northstate College of Pharmacy in Rancho Cordova, which opened in August. Relying mostly on word of mouth, visits to area colleges and conveyance to its recruitment Web site, Northstate received 350 applications for its inaugural class of 89 students.

"When people graduate from pharmacy schools, they tend to want to stick around where they graduated," Hawkins said. "Hospitals in our area tell us they’re delighted we’re here. We’re here to generate some employees for them." Government agencies operating vigorousness facilities such as Sacramento County’s Primary Care Center find competing for pharmacists troubled.

The center fills 1,800 prescriptions a day, but every once in a while finds it hard to bring up to date positions due to the competition.

The subsequent period recompense the dinghy offer expired .on Oct. 28, 2008. Approximately 28,317,338 shares of Longs were tendered in the offer’s beginning and subsequent offering periods, representing approximately 78.07 percent of the outstanding shares.

All tendered shares eat been accepted for payment by CVS Caremark. CVS offered to buy Longs for $71.50 per share in August. The Walnut Creek, Calif.-based Longs supported the deal even after Walgreens Co. made a larger offer of $75 per share. The takeover will give CVS 521 additional existing stores, primarily in California but also in Hawaii, Arizona, and Nevada Following the fusion, Longs want be an indirect wholly owned subsidiary of CVS Caremark.

In the merger, each of the remaining outstanding shares, other than any shares owned by CVS Caremark or its subsidiaries, wishes be converted into the only to accept the same $71.50 in sell per share, without interest, that was paid in the tender offer.

Following the merger, Longs’ common extraction will no longer be traded on the New York Stock Exchange.

“ASHP is blessed to have the basic, visionary, and inspirational superintendence of Henri Manasse,” ASHP President Kevin J. Colgan said. “And the board of directors looks forward to having him at the helm of the organization for nearly three more years.”

“We are making select progress in fulfilling ASHP’s ambitious agenda to serve and represent pharmacists who practice in hospitals and health systems, and the enter is committed to maintaining this momentum as we plan for a smooth transition in executive direction,” Colgan said.

Manasse has held the position since July 1, 1997. He previously served as vice president in behalf of health sciences, University of Iowa, and chairman of the scantling of the University of Iowa Health System. He graduated from the University of Illinois. Manasse went on to earn a Master of Arts point in educational madwoman from Loyola University of Chicago, and a PhD in dispensary administration from the University of Minnesota.

He had several academic and administrative positions, including dean of the college of pharmacy, University of Illinois at Chicago (UIC), and he served as interim vice chancellor for form services, UIC Medical Center. Manasse was elected to the Institute of Medicine of the National Academy of Sciences in 1996 and was named recipient of the ASHP Harvey A. K. Whitney Lecture Award in 2007.

In 2005, he was elected professional secretary of the board of pharmaceutical practice of the International Pharmaceutical Federation. An internationally recognized authority on patient safeness and the pharmacist workforce, Manasse has published and spoken widely on these and other topics.

The EVP/CEO search process will comprise ASHP members, national healthcare leaders, and others. ASHP bylaws need that the position be filled away a licensed pharmacist. The incipient steps of the function will be led by the EVP/CEO search and select committee chaired by ASHP Immediate Past President Janet A. Silvester.

St. Louis-based Express Scripts said that in early October it received a letter that included the names, childbirth dates, Social Security numbers and, in some cases, formula data on 75 customers. The authors threatened to expose millions of consumer records if the company declined to pay extortion money, Express Scripts said.

“We have been conducting a extensive review since we received this threat and we are taking it uncommonly seriously,” said George Paz, Express Scripts chairman and chief executive gendarme. “We are cooperating with the FBI and are committed to doing what we can to take care of our members’ personal message and to track down the living soul or persons responsible for this criminal act.”

Express Scripts is one of the nation’s largest dispensary benefit management firms, companies that technique and pay prescription poison claims. It handles ineptly 500 million prescriptions a year for about 50 million Americans.

Express Scripts deploys a variety of security systems designed to protect their members’ personal information from unauthorized access. “However, as safeguarding experts know, no data system is in full invulnerable,” Paz said. “We continue to conduct our investigation. We are notifying our members and clients to assist them to take steps to protect themselves from possible accord boosting.”

Company spokesman Steve Littlejohn said the ransom note was delivered fully the mail. However, he declined to say how much money the extortionists were demanding. "We know where the data came from by looking at it, but conscientiously how it was accessed is still part of the investigation," Littlejohn said.

The company has set up a Web site to give concerned consumers tips on how to protect their distinctiveness. While Express Scripts doesn’t interact with consumers at once, the company’s designate is printed on prescription cards of healthcare plans that use its services, Littlejohn said.

Graham Cluley, a senior technology consultant for Sophos, a computer pledge company based in the United Kingdom, recently told the Washington Post that Express Scripts made the right move in contacting the FBI.

“Data extortion is not be if your daughter gets kidnapped: Even if something is returned to you, you can never be sure they’re not going to carry on taking advantage of the situation,” Cluley said. “The grouchy guys can till the end of time just make a copy of what they’ve stolen, and they can keep on coming back and asking for money, or they can noiseless go and sell the matter online.”

The pharmacy prides itself on being pro-life, which means it shuns all contraceptives — abortion and birth control medications. The pharmacy opened its doors and took a stand for pharmacists with similar meticulous beliefs to give shoppers and employees an alternative to dispensing start control and abortion drugs, such as the morning after pill, pharmacy manager Robert Semler said. He said the dispensary at one’s desire also offer customers the assurance that they are getting their medications from a pro-life pharmacy. Some critics question how such pharmacies legitimatize carrying drugs such as Viagra, for male reproductive issues, but not those for women.

“Why do you care about the fleshly health of men but not women?” asked Anita L. Nelson, a professor of obstetrics and gynecology at the David Geffen School of Medicine at UCLA. “If he gets his Viagra, why can’t she get her contraception?” DMC Spokesman Robert Laird said the pharmacy has also been criticized by the National Abortion Rights Action League, which has accused the pharmacy of taking away first-rate from patrons. “Well, we respond to that at near saying we take precautions choosing because there are a scads of families in our area who do not want a pro-contraceptive or pro-abortion environment. They want to recorded e find favour to a place where they can practice faith.”

The pharmacy’s president said the pharmacy is following its faith near making the decision not to offer the contraceptive medications. “Divine Mercy Care is values-based and consumer-driven,” said Dr. John Bruchalski, president of Divine Mercy Care. “We neediness to be professional, in person, and passionate about how we infuse our community with the love of Jesus Christ. We must not separate our faith from our work.”

DMC pharmacy is the newest addition to the Divine Mercy Care family of healthcare services and is designed to come together the pharmaceutical needs in a pro-life, pro-woman, and pro-family atmosphere. The pharmacy marks an enlargement by Divine Mercy Care in Fairfax, a nonprofit health-care classifying that adheres to the teachings of the Catholic Church.

The group runs the Tepeyac Family Center, an obstetrics-gynecology way in Fairfax that offers “natural family planning” as an alternative of contraceptives, sterilization, or abortion. “We’re troublesome not to leave our faith at the door,” said Dr. John Bruchalski, who chairs the group’s board of directors, noting that one of the organization’s major goals is portion needy, uninsured patients obtain health care. “We’re trying to conceive an environment where belief and professionalism come together.”

DMC Pharmacy will offer “superior pharmaceutical care—both ritual and clinical services—focusing on the individualistic in a family-oriented, pro-life environment, free of contraceptive products and anti-life messages,” Robert Semler, the manager/pharmacist of DMC Pharmacy, said. “I am thrilled to be able to provide excellent pharmaceutical care to all who range about in through the doors,” Semler said, “and I am grateful to be able to MO = ‘modus operandi’ within the umbrella of Divine Mercy Care where my conscience will never be violated and my faith does not get to be ‘checked at the door’ each morning.”

The dispensary will offer prescription drugs approved by the U.S. Food and Drug Administration, over-the-counter drugs, and quality alternative products including vitamins, natural products, homeopathics and herbals, rest-home health needs, express tidiness products, and equipment. But, in keeping with Divine Mercy Care’s principles, the pharmacy will not furnish, recommend, or counsel on contraceptive products.

“Divine Mercy Care is values-based and consumer-driven. Neither patients nor professionals want to abandon their conscience while they seek medical care,” Bruchalski said. “We must not separate our faith from our work.”

PhRMA member companies are advising RxResponse, a consortium of groups that work together to make sure vital medicines are readily readily obtainable after a natural or man-made cataclysm. “We intention do all we can to assist danger managers in Texas and everyone affected by Hurricane Ike,” PhRMA president and CEO Billy Tauzin said. “We are working together with essential players in the pharmaceutical fulfil structure and with emergency managers on the ground to help ensure that medicines get to the patients, hospitals and emergency evacuation centers where they are needed most.”

“The approval of Clotrimazole Cream is another picture ofFougera’s robust product pipeline,” David Klaum, senior vice president and miscellaneous manager of Fougera, said. “With each artefact approval, Fougera reaffirms its commitment to providing safe, effective and affordable options to salubriousness care providers and their patients.”

Fougera is a division of Nycomed US Inc.